MAA-C002

N/A

Report date: 2025/01/26 18:50:42

NME

Base Information

Drug NameMAA-C002

Drug Alias NameMAA-C002

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTyrosine-protein kinase SRC inhibitorsBcr-Abl tyrosine kinase inhibitors

TargetsBcr-Abl tyrosine kinaseTyrosine-protein kinase SRC

Therapy Area/IndicationsLeukemia, Myelomonocytic, ChronicPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsLeukemia, Myelomonocytic, ChronicPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Inactive IndicationsN/A

ATC CodeN/A